Fmoc-His(Trt)-OH,
109425-51-6,
N-Fmoc-N'-trityl-L-histidine,
MFCD00043332,
N-a-Fmoc-N-im-trityl-L-histidine,
Nalpha-Fmoc-Nim-trityl-L-histidine,
N|A-Fmoc-N(im)-trityl-L-histidine,
Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-,
(2S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1-tritylimidazol-4-yl)propanoic acid,
N-alpha-FMOC-N-Trityl-L-histidine, 98%,
Na-Fmoc-Nim-trityl-L-histidine,
FmocHis(Trt)OH,
Fmoc-his(trityl)-OH,
PubChem10019,
Fmoc-L-His(Trt)-OH,
Fmoc-1-Trityl-His-OH,
AC1Q71CN,
N-Fmoc-1-trityl-L-histidine,
FMOC-HIS(1-TRT)-OH,
SCHEMBL1737899,
N-Fmoc-N\'-trityl-L-histidine,
KS-00000ABI,
DTXSID80465310,
XXMYDXUIZKNHDT-QNGWXLTQSA-N,
C40H33N3O4,
N-|A-Fmoc-N-im-trityl-L-histidine,
Nalpha-Fmoc-tele-trityl-L-histidine,
ANW-16042,
CF-186,
FC1236,
ZINC71788087,
AKOS015924157,
Nalpha-Fmoc-N(im)-trityl-L-histidine,
AC-8594,
AM81823,
AN-7850,
CS-W011428,
AS-12883,
SC-00324,
AB0012546,
AB1002254,
DB-030187,
F0653,
FT-0081964,
FT-0601834,
ST24047275,
M03415,
425F516,
J-300146,
Fmoc-His(Trt)-OH, >=98.0% (sum of enantiomers, HPLC),
N-[(9H-Fluoren-9-Yl-Methoxy)Carbonyl]-1-Trityl-L-Histidine,
N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-im-trityl-L-histidine,
Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-tau-(triphenylmethyl)-L-histidine,
Nalpha-[(9H-Fluoren-9-ylmethoxy)carbonyl]-tele-(triphenylmethyl)-L-histidine,
(2S)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}-3-[1-(triphenylmethyl)-1H-imidazol-4-yl]propanoic acid,
(S)-2-(((9H-fluoren-9-yl)methoxy)carbonylamino)-3-(1-trityl-1H-imidazol-4-yl)propanoic acid,
N-Fmoc-N-trityl-L-histidine,
n-alpha-fmoc-n-im-trityl-l-histidine,
ACN-033271,
CB11086,
CID11422193,
Fmoc-His(Trt)-OH, 99% - 25G 25g,
A7904,
(S)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1-trityl-1H-imidazol-4-yl)propionic acid,
2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(1-tritylimidazol-4-yl)propanoic Acid,
L-Histidine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-1-(triphenylmethyl)-; N-Fmoc-N'-trityl-L-histidine,